Healthy potentially undervalued
Results
6
1 new
Companies which are potentially undervalued and in an acceptable financial position.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
DXRX | UK£1.43 | -0.3% | 14.0% | UK£120.7m | UK£2.13 | 1243.9 | 87.0% | n/a | ||
GSK | UK£19.84 | 3.7% | 33.6% | UK£79.2b | UK£20.77 | 13.6 | 4.7% | 3.6% | ||
HIK | UK£14.80 | 1.2% | -29.5% | UK£3.2b | UK£18.74 | 10.5 | 8.7% | 4.2% | ||
HCM | UK£1.65 | 0.2% | -34.0% | UK£1.4b | UK£3.48 | 4.2 | -67.3% | n/a | ||
OXB | UK£6.00 | -4.0% | 86.0% | UK£725.5m | UK£8.41 | 4.3 | 75.3% | n/a | ||
AZN New | UK£134.62 | -2.4% | 24.4% | UK£208.8b | UK£165.17 | 27.0 | 13.0% | 1.7% |
Page 1 of 1